Simavita to Integrate with Leading Electronic Health & Well Being Solution, Health Metrics' eCase(R) System

SYDNEY, AUSTRALIA--(Marketwired - Nov. 18, 2015) - Simavita Limited ("Simavita" or the "Company") (TSX VENTURE:SV)(ASX:SVA), a global leader in the digital healthcare sector, is pleased to announce the execution of a binding heads of agreement (the "Agreement") with Health Metrics Pty. Ltd. ("Health Metrics"), a provider of clinical care software for the aged care sector. Under the Agreement, Simavita grants a non-exclusive licence to Health Metrics to distribute Simavita's Smart Incontinence Management (SIM™) software in Australia and New Zealand through Health Metrics' eCase® system.

Pursuant to the Agreement, Simavita and Health Metrics will jointly collaborate to integrate SIM™ into the eCase® system and once complete, the integration will result in the SIM™ solution being hosted as a module on the eCase® system.

Health Metrics' eCase® software is a leading electronic solution for Health and Well Being. Amongst other things, eCase® provides a platform for information about each individual aged care resident, their conditions and their personalised care plan. The instrumented 72 hour assessment information collected by SIM™ is an important part of any person centred care plan and information entered into SIM™ will now be able to automatically form the continence care plan data on eCase®. For customers, this will alleviate the double handling of data, introducing time efficiencies and removing the risk of inaccuracies from data entered twice into separate systems.

Modular integration onto the eCase® platform provides seamless access to over 40,000 residential aged care beds across Australia and New Zealand. Under the Agreement, the parties will promote and sell to common and new customers.

Health Metrics is one of the largest providers of clinical software for Health and Well Being to the Aged Care sector in Australia. As such, the integration of SIM™ into the eCase® system will provide Simavita with an outstanding opportunity to present SIM™ to those customers.

"This is a major announcement for both organisations. We're excited about securing this key industry alliance. These partnerships continue to secure our role as thought leaders for the sector. Further, we're proud to be associated with the positive outcomes for the elderly that the leading edge technology from SIM™ can provide", said Steven Strange, CEO of Health Metrics.

"The continence management element of caring for our elderly is vitally important. With integration between SIM™ and eCase®, clinicians who have eCase® will be prompted to run the instrumented SIM™ assessment and incontinence care planning, prompting a best practice approach to incontinence care," commented Simavita CEO, Philippa Lewis.

"We are extremely pleased to be partnering with Health Metrics to integrate SIM™ with the eCase® system. We are confident that this integrated solution will open many doors for Simavita to deploy its unique SIM™ technology. Populating SIM™ data onto electronic care plan platforms already in place will also deliver valuable time savings to carers already using the eCase® system and when combined, the two systems present a compelling proposition for new customers," Mrs. Lewis continued.

For further information, see our website (www.simavita.com).

About Simavita

Simavita is a digital healthcare company that has developed an innovative software platform. The first application for the platform is a world first solution for the management of urinary incontinence, with a focus on the elderly. This platform technology is an instrumented incontinence assessment application that provides evidence-based incontinence management care plans to the residential aged care market.

About SIM™

SIM™ is a wireless sensor technology that delivers evidence-based instrument incontinence data on individuals. SIM™ provides user friendly tools and software to assess the incontinence condition and to help plan better outcomes. SIM™ is used to detect, record and report incontinence events during a compulsory or recommended assessment period in residential aged care facilities to develop an evidence-based incontinence care plan.

Conducting assessments is mandatory in many countries and the incontinence assessment creates an influential element of care of each individual. For more information on Simavita or SIM™, please visit www.simavita.com.

About Health Metrics

Established in 2008, Health Metrics provides intelligent technology and consulting services to the health and ageing sector. Its flagship clinical software system, eCase®, supports the functions of Residential Aged Care, Community Care and Independent Living Units for customers of any size. The company also provides a range of consulting services including but not limited to; Accreditation, Audits, ACFI Uplift and Clinical Training.

Health Metrics is an organisation that is "ahead of the curve" in terms of its ground-breaking research and development as well as scenario modelling for the sector. For more detail, please see www.healthmetrics.com.au.

The TSX Venture Exchange has in no way passed upon the merits of the transactions set out herein and has neither approved nor disapproved the contents of this press release. Neither TSX Venture Exchange not its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this Release.

Forward-Looking Information

This document may contain "forward-looking information" within the meaning of Canadian securities laws ("forward-looking information"). This forward-looking information is given as of the date of this document.

Forward-looking information relates to future events or future performance and reflects Simavita management's expectations or beliefs regarding future events and includes, but is not limited to, information with respect to the successful integration between Simavita's Smart Incontinence Management (SIM™) solution and Health Metrics' electronic care plan solution, and Simavita's strategy and development of its technology. Assumptions upon which such forward-looking information is based include that Simavita will be able to successfully execute on its business plans. Many of these assumptions are based on factors and events that are not within the control of Simavita and there is no assurance they will prove to be correct.

In certain cases, forward-looking information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "budget", "potential", "scheduled", "estimates", "forecasts", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or information that certain actions, events or results "may", "could", "would", "might" or "will be taken", "occur" or "be achieved" or the negative of these terms or comparable terminology. By its very nature forward-looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Simavita to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information. Such factors include, among others, risks related to actual results of current business activities; changes in business plans and strategy as plans continue to be refined; other risks of the medical devices and technology industry; delays in obtaining governmental approvals or financing or in the completion of development activities; as well as those factors detailed from time to time in Simavita's interim and annual financial statements and management's discussion and analysis of those statements. Although Simavita has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking information, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. Simavita provides no assurance that forward-looking information will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information. Accordingly, readers should not place undue reliance on forward-looking information.